Basic Information
ID: ALA4810314
Type: Binding
Description: Inhibition of SARS-CoV-2 3CLpro preincubated for 30 mins followed by addition of (Dabcyl)KTSAVLQSGFRKM(Glu) peptide substrate and measured after 1.5 hrs by FRET assay
Organism: Severe acute respiratory syndrome coronavirus 2
Activity Charts
Bioactivity
Activity Types for Assay ALA4810314
IC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 475.63 | 3.59 | 3.59 |
| 362.47 | 3.20 | 3.20 |
| 572.70 | 2.60 | 2.60 |
| 679.86 | 2.45 | 2.45 |
| 635.79 | 3.97 | 3.97 |
| 536.65 | 3.83 | 3.83 |
| 485.56 | 0.54 | 0.54 |
| 461.60 | 3.34 | 3.34 |
| 464.50 | 1.86 | 1.86 |
| 472.54 | 0.89 | 0.89 |
| 452.56 | 2.45 | 2.45 |
| 403.48 | 1.54 | 1.54 |
| 600.76 | 3.15 | 3.15 |
| 601.75 | 1.96 | 1.96 |
| 504.67 | 1.78 | 1.78 |